Last reviewed · How we verify
NCT07231718
The Effectiveness of an AI-Supported Cyberbullying Awareness Program on Adolescents' Cyberbullying
NA trial testing AI-supported cyberbullying awareness program. in AI-supported Cyberbullying Awareness Program in 45 participants. Enrolling by invitation.
1 April 2026
Quick facts
| Lead sponsor | M. Furkan Kurnaz |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 1 November 2025 |
| Primary completion | 1 April 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- AI-supported cyberbullying awareness program.
Conditions studied
- AI-supported Cyberbullying Awareness Program — all drugs for AI-supported Cyberbullying Awareness Program →
Sponsor
M. Furkan Kurnaz
Who can join
Adults 10 to 17, any sex, with AI-supported Cyberbullying Awareness Program. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With the increasing prevalence of cyberbullying among adolescents today, there is a greater focus on interventions targeting cyberbullying. In Turkey, cyberbullying awareness programs developed in collaboration between the Ministry of National Education (MEB) Directorate General of Special Education and Guidance Services and the United Nations Children's Fund (UNICEF) are being used. This study aims to examine the effectiveness of the cyberbullying awareness program developed by the MEB by enriching it with AI-supported content.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07231718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07231718 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M. Furkan Kurnaz
- Last refreshed: 17 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07231718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing